Zura Bio Limited ZURA
4.04
(0.12)
(2.88%)
as of 25 Sep
- Market cap
- $398.7M
- P/E
- 0.0×
Follow ZURA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
5.58 | 9.05 | 19.33 | 12.90 |
Net Debt/EBITDA |
7.13 | 5.95 | 8.85 | 7.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.77 | 0.49 | 0.78 | 0.79 | |
Capex/Depreciation |
(2.29) | (1.13) | (0.81) | (1.50) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.16) | (0.24) | (0.17) | (0.16) | |
Cash per Share |
1.47 | 1.16 | 2.01 | 1.62 | |
Shareholders Equity per Share |
1.16 | 1.08 | 1.93 | 1.55 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.16 | 1.08 | 1.93 | 1.55 | |
Free Cash Flow |
(15.48) | (22.29) | (18.94) | (20.92) | |
Working Capital |
116.80 | 99.90 | 215.26 | 194.18 | |
Capital Expenditures |
(0.03) | (0.02) | (0.01) | (0.02) | |
Net Current Asset Value |
108.14 | 99.90 | 215.26 | 194.18 | |
| Other line items | |||||
Quick Ratio |
5.45 | 8.82 | 19.21 | 12.57 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.16) | (0.24) | (0.17) | (0.16) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
21.87 | 15.96 | 16.42 | 17.51 | |
Average Assets |
166.50 | 146.74 | 200.57 | 185.60 | |
Average Common Equity |
132.19 | 124.95 | 178.32 | 162.27 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates